UNSPSC 51332855: Levomepromazine hydrochloride

This classification denotes a cns stimulant with the molecular formula C19H24N2OS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42BB1Y2586, chemically known as 10h-phenothiazine-10-propanamine, 2-methoxy-n,n,beta-trimethyl-, monohydrochloride, (r)- (9ci) but more generally known as levomepromazine hydrochloride, which bears US NIH Compound Identifier 102583. European Medicines Agency schedules Levomepromazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02908MIG.

UNSPSC 51332855 Levomepromazine hydrochloride is a Commodity code for a specific pharmaceutical product, but recent state and local procurement activity under this code does not align with its nominal scope. The single recent opportunity—Seminole County, Florida IFB 60459723LAS posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems for community health initiatives, not levomepromazine. The mismatch suggests either a classification error in the county's tagging or a narrow, incidental use of the code. No other state or local opportunities appear in the recent activity for this code.

Seminole County's IFB seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The competitive bid process requires electronic submission through the county's e-Procurement Portal, with all shipping and delivery costs included in vendor proposals. The contract carries a two-year initial term with a one-year renewal option; vendors must provide drug-free workplace certification, E-Verify compliance, and specific insurance coverage including workers' compensation and commercial general liability. The procurement was potentially funded through FEMA, introducing federal compliance requirements. Based on the single, mismatched opportunity available, this code shows little relevant recent activity for levomepromazine procurement in the state and local market.